on DIAGNOSTIC MEDICAL (EPA:ALDMS)
Medical Diagnostics: Revenue Down in Q3 2026
The Diagnostic Medical Systems (DMS) group recorded revenues of 7.9 million euros in the third quarter of 2026, a notable decrease of 28% compared to 2025. This decline is mainly attributed to a wait-and-see approach in Europe, exacerbated by economic and geopolitical tensions.
The Radiology division suffered particularly, with revenue down 44% to €4.9 million. In contrast, the Bone Densitometry sector continued to grow, posting a 34% increase during the same quarter.
Despite this decline, the group remains optimistic about future profitability improvements through targeted operational efficiency measures. DMS anticipates a gradual improvement as the economic environment stabilizes.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DIAGNOSTIC MEDICAL news